{
    "2021-05-24": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Glaxo (GSK)/ Vir Biotech's COVID-19 Antibody Gets CHMP Nod",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Vir Biotech",
                        "COVID-19",
                        "Antibody",
                        "CHMP Nod"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotechnology"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "Eli Lilly's Mirikizumab Improves Fatigue in Crohn's Disease Patients",
                "features": {
                    "keywords": [
                        "Eli Lilly",
                        "Mirikizumab",
                        "Crohn's Disease",
                        "Fatigue"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "The Zacks Analyst Blog Highlights: Sanofi, GlaxoSmithKline, Pfizer, Eli Lilly and Merck",
                "features": {
                    "keywords": [
                        "Zacks Analyst Blog",
                        "Sanofi",
                        "GlaxoSmithKline",
                        "Pfizer",
                        "Eli Lilly",
                        "Merck"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}